Express Pharma
Home  »  Market  »  Express Pharma to host FDD Conclave in Hyderabad

Express Pharma to host FDD Conclave in Hyderabad

Read Article

Showcasing India’s formulation and drug delivery skills, the FDD Conclave is a platform for leading industry professionals to gain the latest learnings, case studies, regulatory insights, and innovative technologies they seek in a rapidly evolving industry segment

The Indian Express (P) and Express Pharma, India’s leading pharma business magazine are organising Formulation Development & Drug Delivery Conclave (FDD). To be held on June 16-17, 2017 at the Novotel, Airport in Hyderabad, for the 100+ leading professionals in attendance, this is the platform for the technologies, innovations and applicable insights they seek in a rapidly evolving segment.

Opportunities galore

As per the February 2017 IBEF report, India is the largest exporter of formulations in terms of volume, with 14 per cent market share and 12th in terms of value. The domestic market is currently valued at $11.2 billion, with double-digit growth expected over the next five years.

On the biosimilars side, with an annual growth rate of 30 per cent, the domestic market is expected to scale $40 billion by 2030. Formulation research and development is sure to increase in tandem, with the government planning to allocate $70 million for local players to develop biosimilars.

What’s more, Indian pharma companies currently spend 8-11 per cent of total turnover on R&D, and the February IBEF report also predicts an increase in R&D spend, which includes formulation R&D, as players try to differentiate themselves by investing heavily in R&D efforts and the development of new drugs.

There is no doubt that drug development and formulation is also a crucial part of India’s drug delivery devices market (estimated at $5.28 billion and expected to touch $14.69 billion by end 2020). Currently dominated by injectables, the sector is also seeing promising work in transdermal, ocular, implantable, oral, nasal, topic and pulmonary drug delivery devices.

Staying ahead of the curve

Adding to this is the possibility of tapping new patient segments, creating branding strategies around innovative drug delivery approaches and meeting evolving regulations. Be it in the discovery and development of new, better medicines or improving existing ones, there is clearly a need for the knowledge of executable strategies and leading-edge technologies.

Come this June, for the 100+ leading professionals in attendance, the two day event will help:

  • Showcase their formulation and drug delivery skills
  • Gain access to solution providers with cutting edge delivery technologies
  • Capture leadership insights from formulation research
  • Present case studies of innovative formulation research and drug delivery projects
  • Discuss regulatory insights comparing device/ product registration in different geographies

Comments are closed.